These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36370349)

  • 1. Protocol for CRISPR/Cas Genome Editing for Investigating Cell Communication Network.
    Okusha Y; Eguchi T
    Methods Mol Biol; 2023; 2582():157-167. PubMed ID: 36370349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (
    Okusha Y; Eguchi T; Tran MT; Sogawa C; Yoshida K; Itagaki M; Taha EA; Ono K; Aoyama E; Okamura H; Kozaki KI; Calderwood SK; Takigawa M; Okamoto K
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene.
    Eguchi T; Kubota S; Kawata K; Mukudai Y; Uehara J; Ohgawara T; Ibaragi S; Sasaki A; Kuboki T; Takigawa M
    Mol Cell Biol; 2008 Apr; 28(7):2391-413. PubMed ID: 18172013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
    Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
    Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
    Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
    J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
    Yeger H; Perbal B
    J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years later..
    Perbal B
    J Cell Commun Signal; 2009 Mar; 3(1):1-3. PubMed ID: 19370402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
    Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
    J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN proteins: opportunities for clinical studies-a personal perspective.
    Yeger H
    J Cell Commun Signal; 2023 Jun; 17(2):333-352. PubMed ID: 37195381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
    Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
    Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
    Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
    Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis.
    MacDonald IJ; Huang CC; Liu SC; Lin YY; Tang CH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying the CCN Proteins in Fibrosis.
    Hutchenreuther J; Leask A; Thompson K
    Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
    Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
    Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.
    Chintala H; Liu H; Parmar R; Kamalska M; Kim YJ; Lovett D; Grant MB; Chaqour B
    J Biol Chem; 2012 Nov; 287(48):40570-85. PubMed ID: 23048035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection, Spinfection, Exofection, and Luciferase Assays for Analysis of CCN Genes Expression Mechanism.
    Eguchi T; Lu Y; Taha EA; Okusha Y
    Methods Mol Biol; 2023; 2582():103-126. PubMed ID: 36370347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characteristics of CCN proteins in tumor development.
    Barreto SC; Ray A; Ag Edgar P
    J BUON; 2016; 21(6):1359-1367. PubMed ID: 28039692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal for a unified CCN nomenclature.
    Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
    Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
    Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
    J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
    Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.